Authors: SHIONOIRI H TAKASAKI I MINAMISAWA K UEDA S KIHARA M SHINDO K HIROTO S SUGIMOTO K HIMENO H NARUSE M NAGAMOCHI I YASUDA G

Citation: H. Shionoiri et al., COUGH-CHALLENGE TRIAL WITH A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, IMIDAPRIL, Journal of clinical pharmacology, 38(5), 1998, pp. 442-446

Authors: SHIONOIRI H NARUSE M MINAMISAWA K UEDA S HIMENO H HIROTO S TAKASAKI I

Citation: H. Shionoiri et al., FOSINOPRIL - CLINICAL PHARMACOKINETICS AND CLINICAL POTENTIAL, Clinical pharmacokinetics, 32(6), 1997, pp. 460-480

Authors: SHIONOIRI H ASHINO K YAMANAKA K SHINDO K HIROTO S ARITA T

Citation: H. Shionoiri et al., EFFECT OF DOXAZOSIN THERAPY ON GLUCOSE-TOLERANCE AND LIPID-METABOLISMIN HYPERTENSIVE PATIENTS WITH IMPAIRED GLUCOSE-TOLERANCE, Clinical therapeutics, 19(3), 1997, pp. 527-536

Authors: SHIONOIRI H ODA H HIROTO S TAKIZAWA T NARUSE M UEDA S TAKASAKI I YASUDA G

Citation: H. Shionoiri et al., THE EFFECT OF TEMOCAPRIL ON MICROALBUMINURIA IN HYPERTENSIVE PATIENTSWITH AND WITHOUT GLUCOSE-INTOLERANCE, Diabetologia, 40, 1997, pp. 1440-1440

Authors: SHIONOIRI H TAKASAKI I KIHARA M HIROTO S SUGIMOTO K YASUDA G GOTOH E ISHII M

Citation: H. Shionoiri et al., WHETHER IMIDAPRIL SELECTIVELY INHIBITS ANGIOTENSIN-II FORMATION RATHER THAN BRADYKININ DEGRADATION, Hypertension, 25(6), 1995, pp. 1388-1388

Authors: SHIONOIRI H ASHINO K YAMANAKA K HIROTO S ARITA T

Citation: H. Shionoiri et al., LONG-TERM DOXAZOSIN THERAPY MAY IMPROVE GLUCOSE AND LIPID-METABOLISM IN HYPERTENSIVES WITH DYSLIPIDEMIA OR DIABETES, Hypertension, 25(6), 1995, pp. 1404-1404